JPRN-UMIN000006813已完成未知
Determination of switching dose from preexisting ESAs to epoetin beta pegol in peritoneal dialysis patients. - Determination of efficacy of epoetin beta pegol in peritoneal dialysis patients
iigata University0 个研究点目标入组 100 人开始时间: 2011年12月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The case whom physician think that the patient should not participate in this study. A patient who has cancer. A patient who has active gastrointestinal bleeding.
研究者
相似试验
已完成
不适用
The examination of appropriate switching dose of epoetin beta pegol from short-acting epoetin in the treatment of anemia in the patients on chronic hemodialysis.Patients on chronic hemodialysisJPRN-UMIN000007839Apheresis and Dialysis Center Keio University, School of Medicine30
已完成
不适用
Determination of minimum and non-provoking doses of soy protein in soy allergic individualssoy allergy10001708food allergyNL-OMON39595FARRP; Food Allergy Research and Resource Program, Department of Food Science & Technology, University of Nebraska10
已完成
不适用
Application observation regarding the dose change of the intrathecally required antispastic drug baclofen via a pump system and the occurrence of postoperative complications in the context of intrathecal baclofen therapy (ITB) in paraplegic patients at the BG Klinikum Hamburg in the period from 1991 to 2021.paralysis-related spasticity in para- & tetraplegicsDRKS00031760BG Klinikum Hamburg95
撤回
不适用
Determination of Minimum and Non-provoking Doses of Soy Protein in Soy Allergic Individualsfood allergysoy allergy10001708NL-OMON34810FARRP: Food Allergy Research and Resource Program5
招募中
1 期
Dose finding study for deciding the optimal dose of fluorescein during probe based confocal endomicroscopyJPRN-UMIN000027696ational Cancer Center Hospital24